Evidence map›Paper›PMID 33299191›Full record

ArticleNature2020

A metastasis map of human cancer cell lines.

Xin Jin, Zelalem Demere, Karthik Nair, Ahmed Ali, Gino B Ferraro, Ted Natoli, Amy Deik, Lia Petronio, Andrew A Tang, Cong Zhu and 9 more

Erratum issuedAbstract read
In one paragraph

Article in Nature, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 269 papers.

0numbers the graph read from it
0cells of the map it votes in
269citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

269 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Cu(I)-N-Heterocyclic carbenes as potent inhibitors of SARS-CoV-2 replication.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2026
    Article
  18. Article
  19. Article
  20. Article

209 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Xin JinBroad Institute of MIT and Harvard, Cambridge, MA, USA. xjin@broadinstitute.org.ORCID http://orcid.org/0000-0003-4167-1743
Zelalem DemereBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Karthik NairBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Ahmed AliBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Gino B FerraroEdwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0002-1587-4259
Ted NatoliBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Amy DeikBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Lia PetronioBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Andrew A TangBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Cong ZhuBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Li WangBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Danny RosenbergBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Vamsi MangenaInstitute for Medical Engineering and Science, Picower Institute for Learning and Memory, Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-2662-0366
Jennifer RothBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Kwanghun ChungBroad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-8167-3340
Rakesh K JainEdwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0001-7571-3548
Clary B ClishBroad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0001-8259-9245
Matthew G Vander HeidenBroad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-6702-4192
Todd R GolubBroad Institute of MIT and Harvard, Cambridge, MA, USA. golub@broadinstitute.org.ORCID http://orcid.org/0000-0003-0113-2403

Funding

VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI MATTHEW G. VANDER HEIDEN · 1985 to 2026
$93.9M
Targeting 15-Prostaglandin Dehydrogenase (15-PGDH) in Cancer Risk, Prevention, and TreatmentR35CA197442 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI MARKOWITZ, SANFORD D. · 2017 to 2023
$6.6M
Understanding the role of metabolism in cancerR35CA242379 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI VANDER HEIDEN, MATTHEW G. · 2019 to 2025
$5.8M
Dissecting Pediatric Brain Tumor Microenvironment to Improve TreatmentR35CA197743 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI JAIN, RAKESH K. · 2015 to 2020
$5.7M
Reengineering obesity-induced abnormal microenvironment to improve PDAC treatmentR01CA208205 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI FUKUMURA, DAI, JAIN, RAKESH K. · 2017 to 2020
$2.2M
An interactive analysis toolkit for single cell RNA-seq in cancer researchU01CA220413 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI JOHNSON, WILLIAM EVAN · 2017 to 2019
$1.2M
Howard Hughes Medical InstituteNCI NIH HHS P30 CA014051NCI NIH HHS R01 CA208205NCI NIH HHS R35 CA197442NCI NIH HHS R35 CA197743NCI NIH HHS R35 CA242379NCI NIH HHS U01 CA220413
6 · The paper itself

Abstract

Most deaths from cancer are explained by metastasis, and yet large-scale metastasis research has been impractical owing to the complexity of in vivo models. Here we introduce an in vivo barcoding strategy that is capable of determining the metastatic potential of human cancer cell lines in mouse xenografts at scale. We validated the robustness, scalability and reproducibility of the method and applied it to 500 cell lines

Indexed as

Cell MovementOrgan SpecificityAnimalsBrain NeoplasmsBreast NeoplasmsCell Line, TumorElectronic Data ProcessingFemaleHeterograftsHumansLipid MetabolismMiceMolecular TypingMutationNeoplasm MetastasisNeoplasm Transplantation

Identifiers

PMID33299191
PMCPMC8439149

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.